Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 290

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 290
---
 Total assets                                $                 107,388      $         86,204  

The accompanying notes are an integral part of
the consolidated financial statements.

F-3

ALPHA TAU MEDICAL LTD. AND ITS SUBSIDIARIES

CONSOLIDATED
BALANCE SHEETS

U. S. dollars in thousands (except share
and per share data)

                                                                                                                                                                                        December 31,                                          
                                                                                                                                                                                        2023                             2024                 
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                                                                                                                        
  CURRENT LIABILITIES:                                                                                                                                                                                                                        
  Trade payables                                                                                                                                                                        $                     2,566      $             3,531  
  Other payables and accrued expenses                                                                                                                                            6                            3,474                    4,133  
  Current maturities of operating lease liabilities                                                                                                                              5                            1,062                    1,011  
  Total current liabilities                                                                                                                                                                                   7,102                    8,675  
  LONG-TERM LIABILITIES:                                                                                                                                                                                                                      
  Long-term loan                                                                                                                                                                 7                            5,610                    5,561  
  Warrants liability                                                                                                                                                             8                            3,597                    3,338  
  Operating lease liabilities                                                                                                                                                    5                            6,604                    5,964  
  Total long-term liabilities                                                                                                                                                                                15,811                   14,863  
  Total liabilities                                                                                                                                                                                          22,913                   23,538  
  COMMITMENTS AND CONTINGENCIES                                                                                                                                                 11                                                            
  SHAREHOLDERS’ EQUITY:                                                                                                                                                                                                                       
  Ordinary shares of no -par value per share –                                                                                                                                  12                                -                        -  
  Additional paid-in capital                                                                                                                                                                                200,234                  210,175  
  Accumulated deficit                                                                                                                                                                                     ( 115,759                ( 147,509  
  Total shareholders’ equity                                                                                                                                                                                 84,475                   62,666  
  Total liabilities and shareholders’                                                                                                                                                   $                   107,388      $            86,204  

The accompanying notes are an integral part of
the consolidated financial statements.

F-4

ALPHA TAU MEDICAL LTD. AND ITS SUBSIDIARIES

CONSOLIDATED
STATEMENTS OF OPERATIONS

U. S. dollars in thousands (except share
and per